`
`Application/Control No.
`
`15/121523
`
`STEPHEN RAWLINGS
`U.S. PATENT DOCUMENTS
`
`Applicant(s)/Patent Under
`Reexamination
`GEUIJEN ET AL.
`Art Unit
`
`1643
`
`Page 2 Of 8
`
`Document Number
`Country Code-Number- Kind Code
`
`Date
`MM -YYYY
`
`CPC Classification
`
`US Classification
`
`Document Number
`Country Code-Number-Kind Code
`
`Date
`MM-YYYY
`
`Country
`
`FOREIGN PATENT DOCUMENTS
`
`ClaSSification
`
`
`EIHIIHHIHEIEH-CCCCCCCCCCCCCq)q)q)q)q)q)q)q)q)q)q)q)q)
`
`
`
`NON-PATENT DOCUMENTS
`
`Include as applicable: Author, Title Date, Publisher, Edition or Volume, Pertinent Pages)
`
`Boyer et aI. (Int. J. Cancer. 1999; 82: 525-531)
`
`Press et al. (J. Immunol. 1988 Dec 15; 141 (12): 4410-4417)
`
`- U
`
`W Riemer et aI. (Mol. Immunol. 2005; 42: 1121-1124)
`
`Greenspan et al. (Nature Biotechnology. 1999; 7: 936-937)
`
`*A copy of this reference is not being furnished with this Office action. (See MPEP § 707.05(a).)
`Dates in MM-YYYY format are publication dates. Classifications may be US or foreign.
`US. Patent and Trademark Office
`
`PTO-892 (Rev. 01-2001)
`
`Notice of References Cited
`
`Part of Paper No. 20171114
`
`
`
`
`
`